[PDF] from arxiv.orgDA Riechers, A Cooray, A Omont… - The Astrophysical …, 2011 - iopscience.iop.org DOMINIk A. RIECHERS1,28, A. COORAY1,2, A. OMONT3, R. NERI4, AI HARRIS5, AJ BAkER6, P. COX4, DT FRAYER7, JM CARPENTER1, R. AULD8, H. AUSSEL9, A. BEELEN10, R. BLUNDELL11, J. BOCk1,12, D. BRISBIN13, D. BURGARELLA14, P. ... Cited by 1 - Related articles - All 6 versions
[PDF] from arxiv.orgJ Richard, JP Kneib, H Ebeling, D Stark… - Arxiv preprint arXiv: …, 2011 - arxiv.org Johan Richard1,2⋆, Jean-Paul Kneib3, Harald Ebeling4, Daniel P. Stark5, Eiichi Egami6, Andrew K. Fiedler6 1CRAL, Observatoire de Lyon, Université Lyon 1, 9 Avenue Ch. André, 69561 Saint Genis Laval Cedex, France 2Dark Cosmology Centre, Niels Bohr Institute, University of ... Cited by 4 - Related articles - All 5 versions
C Hansen, J Moussouris… - US Patent 7,952,587, 2011 - Google Patents IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIW US007952587B2 (12) United States Patent ao) Patent no.: us 7,952,587 B2 Hansen et al. (45) Date of Patent: *May 31,2011 (54) PROCESSOR AND METHOD FOR EXECUTING INSTRUCTIONS REQUIRING WIDE OPERANDS FOR MULTIPLY MATRIX OPERATIONS ... Related articles - All 3 versions
K Oechsle, F Honecker, T Cheng… - Annals of …, 2011 - Eur Soc Med Oncology Results: Sunitinib demonstrated comparable dose-dependent growth inhibition in cisplatin-sensitive and cisplatin-resistant cell lines, with IC 50 between 3.0 and 3.8 μM. Patient characteristics were as follows: median of 2 (1–6) cisplatin-containing regimens; high-dose chemotherapy ... Cited by 2 - Related articles - All 2 versions